Showing 2301-2310 of 8165 results for "".
Behind the Pulse: Considerations for evaluating a picosecond laser
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/behind-the-pulse-considerations-for-evaluating-a-picosecond-laser/19749/If you are considering a picosecond system, this is the one webinar you will want to see. With content developed by Candela’s VP of Technology Research and Distinguished Fellow, Xiaoming Shang, PhD, along with a presentation by Perry Tomasetti, Candela’s Senior Director, Product Development, you wilThe Acne Therapy Pipeline
https://practicaldermatology.com/topics/acne-rosacea/the-acne-therapy-pipeline/19724/From new agents to improved formulations, Lawrence Eichenfield, MD breaks down the latest advances in acne therapy.Try New Things
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/try-new-things/19690/For the field of aesthetics to move forward, innovation is essential. Brian Biesman, MD discusses a responsible approach to trying new things in the clinical setting and stresses the need for caution at times.Microneedling v. Fractional Resurfacing: When and Why
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/microneedling-v-fractional-resurfacing-when-and-why/19688/Data suggest that microneedling can be as effective as nonablative fractional resurfacing for improvement of acne scars. So when is each indicated? Deirdre Hooper, MD discusses a role for combination approaches.Education is Essential
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/education-is-essential/19680/How do you integrate aesthetics into a new practice, and how do you get patients to understand the basics of skincare? Heidi Prather, MD says that education of both staff and patients is key.Close Up: Exploring New Research in Metastatic Melanoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/close-up-exploring-new-research-in-metastatic-melanoma/19673/Adil Daud, MD discusses the promising results of a new study looking at the use of Tafinlar (dabrafenib) and Mekinist (trametinib) in BRAF-mutated advanced melanoma.Elastin - The underappreciated skin fundamental
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/elastin-the-underappreciated-skin-fundamental/19672/Join Macrene Alexiades, MD, PhD, FAAD as she discusses elastin and its role as a critical, yet often underappreciated, skin fundamental. In this webinar, she explains why lack of elastin is the root cause of skin laxity and what happens when there is a cessation of elastin synthesis. Dr. Alexiades rAI: What it Means for Medicine
https://practicaldermatology.com/topics/practice-management/ai-what-it-means-for-medicine/19636/Justin Ko, MD, MBA shares his thoughts on how artificial and augmented intelligence will impact dermatology and discusses the AAD’s recent position statement on this technology.The Skin Cancer Foundation at 40
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-skin-cancer-foundation-at-40/19614/Skin Cancer Foundation president Deborah Sarnoff, MD talks about the Foundation's accomplishments, its current focus, and future goals. Founded in 1979, the foundation has helped educate the public on skin cancer risk and supports dermatologists in practice.Effective Communication: Achieve Results You Want
https://practicaldermatology.com/topics/practice-management/effective-communication-achieve-results-you-want/19593/Kalyani Marathe, MD describes the Path to Action plan that can help you improve your communication skills—whether you're presenting, consulting with colleagues, or talking to patients. She offers tips for assessing your skills and finding ways to change your approach when needed.